• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana
Conclusion The results of our study indicate a high incidence of non-serious AEFI and the rare occurrence of serious AEFI after COVISHIELD vaccination in healthcare workers. The rate of AEFI was higher after the first dose than after the second dose. Sex, age, previous SARS-CoV-2 infection, allergies and comorbidity were not significantly associated with the onset and duration of AEFI.
Source: BMJ Open - June 28, 2023 Category: General Medicine Authors: Marfoh, K., Samba, A., Okyere, E., Acheampong, F., Owusu, E., Darko, D. N. A., Zakariah, J., Mensa, H., Aidoo, E., Mohammed, Y. Tags: Open access, Immunology (including allergy), COVID-19 Source Type: research

Why You Should Rest —a Lot—If You Have COVID-19
Until recently, running was a major part of Emma Zimmerman’s life. The 26-year-old freelance journalist and graduate student was a competitive distance runner in college and, even after she graduated, logged about 50 miles per week. So she tentatively tried to return to her running routine roughly a week after a probable case of COVID-19 in March, doing her best to overcome the malaise that followed her initial allergy-like symptoms. Each time, though, “I’d be stuck in bed for days with a severe level of crippling fatigue,” Zimmerman says. Months later, Zimmerman still experiences health issues incl...
Source: TIME: Health - September 23, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination
CONCLUSION: COVID-19 vaccination might be associated with VKH disease development, and the ingredients of the mRNA vaccine or viral peptide encoded by mRNA may have activated the immunological process and induced VKH disease.PMID:35404752 | DOI:10.1080/09273948.2022.2053547
Source: Ocular Immunology and Inflammation - April 11, 2022 Category: Allergy & Immunology Authors: Chan Woong Joo Yong-Kyu Kim Sung Pyo Park Source Type: research

NIDCR's Spring 2022 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2022 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NIDCR News Science Advances   NIDCR News NIH & NIDCR Release “Oral Health in America: Advances and Challenges” In December, NIDCR announced the release of a report that provides a comprehensive snapshot of oral health in America, detailing 20 years of advances and challenges and drawing on data from public research and evidence-based practices. For more ...
Source: NIDCR Science News - March 3, 2022 Category: Dentistry Source Type: news

Active Symptom-Based Surveillance of Adverse Events Following Immunization among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala
CONCLUSION: All the adverse reactions were of a minor type and non-serious. Side effects were less common in older adults (>60 years). Reactions to the second dose were lesser in intensity and frequency. Younger age, history of allergy, and comorbidities, particularly asthma were found to be major predictors for the development of adverse events and require more watchful vaccine administration.PMID:35135453 | DOI:10.2174/1574886317666220207120649
Source: Current Drug Safety - February 9, 2022 Category: Drugs & Pharmacology Authors: Maria Jose Priyanka Rajmohan Joe Thomas Swathi Krishna Beena Antony Unnikrishnan U G Elsy M I Raphael M P Ponnu Jose Lucy Raphael Praveenlal Kuttichira Source Type: research

Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccine
CONCLUSIONS: Both local and systemic acute effects after second dose of BNT162b2 vaccine were frequently reported. However, symptoms were mostly light/mild and of short duration. Thus, our findings support the safety of COVID-19 vaccination in adults in relatively good health.PMID:34939617 | DOI:10.23749/mdl.v112i6.12507
Source: Medicina del Lavoro - December 23, 2021 Category: Occupational Health Authors: Elisa Borroni Dario Consonni Massimo Cugno Andrea Lombardi Davide Mangioni Patrizia Bono Massimo Oggioni Sara Uceda Renteria Lorenzo Bordini Carlo Domenico Nava Matteo Letzgus Flaminia Gentiloni Silverj Silvana Castaldi Magda Rognoni Luca Cavallieri D'Oro Source Type: research

Pages: 1  2  3  4  5  6  7  8  9